cbdMD (NYSEAMERICAN:YCBD) Shares Down 1.9%

Shares of cbdMD, Inc. (NYSEAMERICAN:YCBDGet Free Report) fell 1.9% during mid-day trading on Wednesday . The stock traded as low as $0.95 and last traded at $1.01. 395,192 shares were traded during mid-day trading, an increase of 36% from the average session volume of 290,307 shares. The stock had previously closed at $1.03.

cbdMD Price Performance

The firm has a market cap of $3.08 million, a PE ratio of -0.08 and a beta of 2.11.

cbdMD (NYSEAMERICAN:YCBDGet Free Report) last released its earnings results on Tuesday, February 13th. The company reported ($0.67) earnings per share (EPS) for the quarter. cbdMD had a negative net margin of 87.07% and a negative return on equity of 118.28%. The business had revenue of $5.38 million during the quarter.

Hedge Funds Weigh In On cbdMD

Several institutional investors have recently bought and sold shares of YCBD. Renaissance Technologies LLC lifted its stake in cbdMD by 49.3% in the first quarter. Renaissance Technologies LLC now owns 93,600 shares of the company’s stock valued at $97,000 after purchasing an additional 30,900 shares during the last quarter. Vident Investment Advisory LLC lifted its position in shares of cbdMD by 68.4% during the first quarter. Vident Investment Advisory LLC now owns 119,283 shares of the company’s stock worth $124,000 after acquiring an additional 48,470 shares in the last quarter. Prudential Financial Inc. purchased a new stake in shares of cbdMD during the second quarter worth $32,000. Vanguard Group Inc. lifted its position in shares of cbdMD by 11.9% during the third quarter. Vanguard Group Inc. now owns 1,304,682 shares of the company’s stock worth $294,000 after acquiring an additional 139,081 shares in the last quarter. Finally, Jane Street Group LLC purchased a new stake in shares of cbdMD during the first quarter worth $28,000. Hedge funds and other institutional investors own 7.18% of the company’s stock.

About cbdMD

(Get Free Report)

cbdMD, Inc produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids.

Read More

Receive News & Ratings for cbdMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for cbdMD and related companies with MarketBeat.com's FREE daily email newsletter.